Implementation of the New European Health Technology Assessment Regulation (HTAR)
Mastering the New European Health Technology Assessment Regulation (HTAR)
Your Essential Guide to Successful Market Access in the EU
Are you ready for the 2025 EU HTA changes?
The European Health Technology Assessment Regulation (HTAR) is transforming market access for medicinal products, in vitro diagnostics, and high-risk medical devices. If your company is planning to launch in Europe, understanding the new Joint Clinical Assessment (JCA) process is critical.
Our latest white paper, "Implementation of the New European Health Technology Assessment Regulation (HTAR)," offers a deep dive into what these changes mean for your business—and how to navigate them effectively.
What You'll Learn:
- The HTAR timeline and what’s changing in 2025, 2028, and 2030
- The JCA submission process—what’s required and how to prepare
- Key challenges in compliance and how to overcome them
- ProPharma’s approach to ensuring a smooth EU market entry
Why This Whitepaper is a Must-Read:
- Expert insights from regulatory and HTA specialists
- Practical strategies to streamline your product launch
- Actionable guidance to reduce delays and resource strain
Download the Whitepaper Now
Don’t let regulatory complexity slow down your EU market entry. Get the expert guidance you need—right now.
Originally published on 6/27/2024. Whitepaper updated as of January 2025.
ProPharma: Your Partner in Regulatory Success
Ensure your team is prepared for the new Health Technology Assessment Regulation (HTAR) in Europe. For personalized support on HTAR compliance and market access, contact us today.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...